Lenacapavir: Revolutionary HIV Prevention Drug Named 2024 Breakthrough of the Year
Science Magazine named lenacapavir its 2024 Breakthrough of the Year. In clinical trials, the twice-yearly injection provided complete protection against HIV infection — none of the 2,134 women who received the drug in the PURPOSE 1 trial contracted the virus.
The drug works through a novel mechanism, targeting multiple stages of the HIV life cycle simultaneously. Unlike daily pills, the long-acting injection only needs to be administered every six months, dramatically improving adherence.
“In clinical trials, the twice-yearly injection provided complete protection against HIV infection — none of the 2,134 women who received the drug in the PURPOSE 1 trial contracted the virus.”
"This could be transformative for HIV prevention," said Dr. Anthony Fauci. The breakthrough offers hope that the decades-long AIDS epidemic could finally be brought under control, especially in regions where daily medication regimens are challenging to maintain.
How did this story make you feel?
📎 Cite this article
Good News Good Vibes. (2024, December 19). Lenacapavir: Revolutionary HIV Prevention Drug Named 2024 Breakthrough of the Year. Retrieved from https://goodnewsgoodvibes.com/en/article/lenacapavir-hiv-prevention-breakthrough-2024
https://goodnewsgoodvibes.com/en/article/lenacapavir-hiv-prevention-breakthrough-2024
Editorial Team
Our editorial team curates and verifies positive news from credible sources worldwide.
Last reviewed: March 21, 2026
Trending
LHCb Collaboration Discovers New Proton-Like Particle with Two Charm Quarks
Science · 5 min
Johannes Høsflot Klæbo Wins Six Golds at 2026 Winter Olympics — New Record
Sports · 4 min
Renewables Overtake Coal as World's Top Electricity Source for First Time
Environment · 5 min
Shingles Vaccine Cuts Risk of Major Cardiac Events by 46%, Landmark Study Finds
Health · 5 min
Monarch Butterfly Population Surges 64% in Mexico Overwintering Season
Animals · 4 min
